Lantern Pharma Inc. · NASDAQ:LTRN

Armistice Capital, LLC reported a 9.99% stake in Lantern Pharma Inc. (Schedule 13G)

Event Sep 30, 2026 · Filed Nov 16, 2026

Armistice Capital, LLC reported a 9.99% stake in Lantern Pharma Inc., 1,542,681 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G).

Stake
9.99%
Shares
1,542,681
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC9.99%1,542,681
Steven Boyd9.99%1,542,681

Source

Download original · View original at SEC

Related